NCT07150013View on ClinicalTrials.gov

Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

October 15, 2026

Conditions

Rett Syndrome

Interventions

DRUG

Vorinostat (SAHA)

oral suspension

DRUG

Placebo

placebo

Trial Locations (1)

Unknown

Grupo de Investigación Clínica PECET (GIC-PECET), Medellín

All Listed Sponsors

lead

Unravel Biosciences, Inc.

INDUSTRY